• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞衍生的 CHI3L1 通过激活 MAF/CTLA4 信号通路促进三阴性乳腺癌的免疫逃逸。

Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.

机构信息

Special Medical Service Center, General Surgery, Zhujiang Hospital of Southern Medical University, No. 253, Middle Gongye Avenue, Haizhu District, Guangzhou, 510280, Guangdong, People's Republic of China.

Department of Breast Surgery, The First People's Hospital of Foshan, Foshan, 528000, People's Republic of China.

出版信息

J Transl Med. 2023 Oct 14;21(1):721. doi: 10.1186/s12967-023-04532-6.

DOI:10.1186/s12967-023-04532-6
PMID:37838657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10576881/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) development may be associated with tumor immune escape. This study explores whether the CHI3L1/MAF/CTLA4/S100A4 axis affects immune escape in TNBC through interplay with triple-negative breast cancer stem cells (TN-BCSCs).

OBJECTIVE

The aim of this study is to utilize single-cell transcriptome sequencing (scRNA-seq) to uncover the molecular mechanisms by which the CHI3L1/MAF/CTLA4 signaling pathway may mediate immune evasion in triple-negative breast cancer through the interaction between tumor stem cells (CSCs) and immune cells.

METHODS

Cell subsets in TNBC tissues were obtained through scRNA-seq, followed by screening differentially expressed genes in TN-BCSCs and B.C.s (CD44 and CD24) and predicting the transcription factor regulated by CHI3L1. Effect of CHI3L1 on the stemness phenotype of TNBC cells investigated. Effects of BCSCs-231-derived CHI3L1 on CTLA4 expression in T cells were explored after co-culture of BCSCs-231 cells obtained from microsphere culture of TN-BCSCs with T cells. BCSCs-231-treated T cells were co-cultured with CD8 T cells to explore the resultant effect on T cell cytotoxicity. An orthotopic B.C. transplanted tumor model in mice with humanized immune systems was constructed, in which the Role of CHI3L1/MAF/CTLA4 in the immune escape of TNBC was explored.

RESULTS

Eight cell subsets were found in the TNBC tissues, and the existence of TN-BCSCs was observed in the epithelial cell subset. CHI3L1 was related to the stemness phenotype of TNBC cells. TN-BCSC-derived CHI3L1 increased CTLA4 expression in T cells through MAF, inhibiting CD8 T cell cytotoxicity and inducing immunosuppression. Furthermore, the CTLA4 T cells might secrete S100A4 to promote the stemness phenotype of TNBC cells.

CONCLUSIONS

TN-BCSC-derived CHI3L1 upregulates CTLA4 expression in T cells through MAF, suppressing the function of CD8 T cells, which promotes the immune escape of TNBC.

摘要

背景

三阴性乳腺癌(TNBC)的发展可能与肿瘤免疫逃逸有关。本研究探讨 CHI3L1/MAF/CTLA4/S100A4 轴是否通过与三阴性乳腺癌干细胞(TN-BCSC)相互作用影响 TNBC 的免疫逃逸。

目的

本研究旨在利用单细胞转录组测序(scRNA-seq)揭示 CHI3L1/MAF/CTLA4 信号通路通过肿瘤干细胞(CSC)与免疫细胞相互作用介导三阴性乳腺癌免疫逃逸的分子机制。

方法

通过 scRNA-seq 获取 TNBC 组织中的细胞亚群,筛选 TN-BCSC 和 B.C.(CD44 和 CD24)中差异表达的基因,并预测 CHI3L1 调控的转录因子。研究 CHI3L1 对 TNBC 细胞干性表型的影响。在 TN-BCSC 的微球培养物中分离出 BCSC-231 细胞与 T 细胞共培养后,探讨 BCSC-231 细胞来源的 CHI3L1 对 T 细胞 CTLA4 表达的影响。将 BCSC-231 处理的 T 细胞与 CD8 T 细胞共培养,探讨对 T 细胞细胞毒性的影响。构建具有人源化免疫系统的荷人原位乳腺癌移植瘤模型,探讨 CHI3L1/MAF/CTLA4 在 TNBC 免疫逃逸中的作用。

结果

在 TNBC 组织中发现了 8 种细胞亚群,在上皮细胞亚群中观察到 TN-BCSC 的存在。CHI3L1 与 TNBC 细胞的干性表型有关。TN-BCSC 衍生的 CHI3L1 通过 MAF 增加 T 细胞中 CTLA4 的表达,抑制 CD8 T 细胞的细胞毒性并诱导免疫抑制。此外,CTLA4 T 细胞可能分泌 S100A4 来促进 TNBC 细胞的干性表型。

结论

TN-BCSC 衍生的 CHI3L1 通过 MAF 上调 T 细胞中 CTLA4 的表达,抑制 CD8 T 细胞的功能,从而促进 TNBC 的免疫逃逸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/28230f57cad3/12967_2023_4532_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/bbf6aa02802c/12967_2023_4532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/e19131c832e9/12967_2023_4532_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/341a7b1d08f7/12967_2023_4532_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/67416f364e5a/12967_2023_4532_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/d6d7daa7a6ce/12967_2023_4532_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/fb94361a95ef/12967_2023_4532_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/40b7ca439771/12967_2023_4532_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/28230f57cad3/12967_2023_4532_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/bbf6aa02802c/12967_2023_4532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/e19131c832e9/12967_2023_4532_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/341a7b1d08f7/12967_2023_4532_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/67416f364e5a/12967_2023_4532_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/d6d7daa7a6ce/12967_2023_4532_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/fb94361a95ef/12967_2023_4532_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/40b7ca439771/12967_2023_4532_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c17/10576881/28230f57cad3/12967_2023_4532_Fig8_HTML.jpg

相似文献

1
Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.癌症干细胞衍生的 CHI3L1 通过激活 MAF/CTLA4 信号通路促进三阴性乳腺癌的免疫逃逸。
J Transl Med. 2023 Oct 14;21(1):721. doi: 10.1186/s12967-023-04532-6.
2
NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.NOTCH4 通过转录激活 SLUG 和 GAS1 维持三阴性乳腺癌中静止的间充质样乳腺癌干细胞。
Theranostics. 2020 Jan 19;10(5):2405-2421. doi: 10.7150/thno.38875. eCollection 2020.
3
STAT3 as a promising chemoresistance biomarker associated with the CD44/CD24/ALDH BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line.STAT3 作为一种有前途的化疗耐药生物标志物,与三阴性乳腺癌(TNBC)细胞系中的 CD44/CD24/ALDH BCSCs 样亚群相关。
Exp Cell Res. 2018 Feb 15;363(2):283-290. doi: 10.1016/j.yexcr.2018.01.018. Epub 2018 Jan 17.
4
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.鉴定与三阴性乳腺癌中 BET 抑制相关的干性相关基因谱。
Cell Oncol (Dordr). 2020 Jun;43(3):431-444. doi: 10.1007/s13402-020-00497-6. Epub 2020 Mar 12.
5
Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.鉴定 tRNA 衍生的小非编码 RNA 作为预测三阴性乳腺癌复发的潜在生物标志物。
Cancer Med. 2018 Oct;7(10):5130-5144. doi: 10.1002/cam4.1761. Epub 2018 Sep 21.
6
Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.三阴性乳腺癌中不同状态的癌症干细胞的转录谱。
Mol Cancer. 2018 Feb 23;17(1):65. doi: 10.1186/s12943-018-0809-x.
7
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.MCT-1/miR-34a/IL-6/IL-6R 信号轴促进三阴性乳腺癌中的 EMT 进展、癌症干性和 M2 巨噬细胞极化。
Mol Cancer. 2019 Mar 18;18(1):42. doi: 10.1186/s12943-019-0988-0.
8
Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.乳腺癌干细胞中 SCUBE2 表达上调通过调节 Notch 信号通路和上皮间质转化增强三阴性乳腺癌的侵袭性。
Exp Cell Res. 2018 Sep 15;370(2):444-453. doi: 10.1016/j.yexcr.2018.07.008. Epub 2018 Jul 5.
9
FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance.FBXL2促进E47蛋白不稳定,以抑制乳腺癌干性和紫杉醇耐药性。
Oncogene. 2023 Jan;42(5):339-350. doi: 10.1038/s41388-022-02559-5. Epub 2022 Dec 2.
10
Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling.靶向 DCLK1 通过抑制 IL-6/STAT3 信号通路衰减三阴性乳腺癌肿瘤干细胞特性并诱导抗肿瘤免疫。
Breast Cancer Res. 2023 Apr 17;25(1):43. doi: 10.1186/s13058-023-01642-3.

引用本文的文献

1
Role of chitinase-3-like protein 1 in liver diseases: A comprehensive review.几丁质酶-3样蛋白1在肝脏疾病中的作用:综述
Genes Dis. 2025 Apr 24;12(6):101653. doi: 10.1016/j.gendis.2025.101653. eCollection 2025 Nov.
2
Identification of cell adhesion related signature for molecular subtyping and prognostic prediction in acute myeloid leukemia.急性髓系白血病中用于分子亚型分型和预后预测的细胞粘附相关特征识别
Discov Oncol. 2025 Jul 23;16(1):1397. doi: 10.1007/s12672-025-03208-5.
3
Future Perspectives and Conclusions from Animal Models of CHI3L1-Related Inflammation-Associated Cancer.

本文引用的文献

1
Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.细胞毒性 T 淋巴细胞相关抗原 4 多态性与乳腺癌易感性:荟萃分析证据。
J Chin Med Assoc. 2023 Feb 1;86(2):207-219. doi: 10.1097/JCMA.0000000000000851. Epub 2023 Jan 18.
2
Diverse Begomoviruses Evolutionarily Hijack Plant Terpenoid-Based Defense to Promote Whitefly Performance.不同的 Bego 病毒通过进化劫持植物萜烯类防御来促进粉虱的表现。
Cells. 2022 Dec 30;12(1):149. doi: 10.3390/cells12010149.
3
Single-intraosseous simvastatin injection suppresses cancers via activating CD8 T cells.
与CHI3L1相关的炎症相关癌症动物模型的未来展望与结论
Cells. 2025 Jun 26;14(13):982. doi: 10.3390/cells14130982.
4
GRB2 Promotes Malignant Behaviors of Breast Cancer by Modulating the Global Expression and Alternative Splicing Profiles in SK-BR-3 Cells Through Binding mRNA.GRB2通过与mRNA结合调控SK-BR-3细胞中的整体表达和可变剪接谱,促进乳腺癌的恶性行为。
Cancer Med. 2025 May;14(10):e70905. doi: 10.1002/cam4.70905.
5
Immune evasion and resistance in breast cancer.乳腺癌中的免疫逃逸与耐药性。
Am J Cancer Res. 2025 Apr 15;15(4):1517-1539. doi: 10.62347/PNGT6996. eCollection 2025.
6
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.重编程乳腺肿瘤免疫微环境:从冷到热的转变以增强免疫治疗
J Exp Clin Cancer Res. 2025 Apr 25;44(1):131. doi: 10.1186/s13046-025-03394-8.
7
New insights on anti-tumor immunity of CD8 T cells: cancer stem cells, tumor immune microenvironment and immunotherapy.CD8 T细胞抗肿瘤免疫的新见解:癌症干细胞、肿瘤免疫微环境与免疫治疗
J Transl Med. 2025 Mar 17;23(1):341. doi: 10.1186/s12967-025-06291-y.
8
Multi-Omics Profiling Identifies a High-Risk Subgroup of Breast Cancer Stem Cells for Prognostic Stratification and Personalized Treatment.多组学分析鉴定出用于预后分层和个性化治疗的乳腺癌干细胞高风险亚组。
J Cancer. 2025 Feb 28;16(6):1860-1872. doi: 10.7150/jca.109589. eCollection 2025.
9
Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model.菊苣酸与PD-1/PD-L1阻断剂联合治疗可改善患者来源的卵巢癌异种移植模型中的免疫治疗反应。
Cell Commun Signal. 2025 Mar 14;23(1):137. doi: 10.1186/s12964-025-02146-7.
10
Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.壳聚糖介导体抑制几丁质酶样蛋白减少肿瘤免疫抑制,抑制淋巴转移,并增强互补三阴性乳腺癌模型中的抗 PD-1 疗效。
Breast Cancer Res. 2024 Apr 11;26(1):63. doi: 10.1186/s13058-024-01815-8.
单次骨内注射辛伐他汀通过激活CD8 T细胞抑制癌症。
Biomed Pharmacother. 2022 Nov;155:113665. doi: 10.1016/j.biopha.2022.113665. Epub 2022 Sep 12.
4
CTLA-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer.CTLA-4:作为乳腺癌中的免疫抑制性免疫检查点。
Curr Mol Med. 2023;23(6):521-526. doi: 10.2174/1566524022666220610094716.
5
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies.miRNA 在肿瘤免疫逃逸中的作用及基于 miRNA 的治疗策略。
Front Immunol. 2022 Jan 18;12:807895. doi: 10.3389/fimmu.2021.807895. eCollection 2021.
6
Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma.肝细胞癌中m6A调节因子相关长链非编码RNA的预后预测模型的鉴定与验证
Front Mol Biosci. 2021 Dec 20;8:784553. doi: 10.3389/fmolb.2021.784553. eCollection 2021.
7
The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives.氨来呫诺在癌症治疗中的潜在价值:分子靶点与治疗展望。
Biochem Pharmacol. 2022 Mar;197:114895. doi: 10.1016/j.bcp.2021.114895. Epub 2021 Dec 28.
8
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1.细胞毒性颗粒机制的瘫痪是一种新的癌症免疫逃避机制,由几丁质酶 3 样蛋白 1 介导。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003224.
9
MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.微小RNA-30e*通过破坏NF-κB/IκBα负反馈环在原位异种移植模型中促进人胶质瘤细胞的侵袭性。
J Clin Invest. 2021 Nov 15;131(22). doi: 10.1172/JCI155916.
10
Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis.单细胞RNA测序揭示乳腺癌淋巴结转移的细胞异质性和转录组图谱。
Oncogenesis. 2021 Oct 5;10(10):66. doi: 10.1038/s41389-021-00355-6.